The American Heart Association and the American Stroke Association updated guidelines for the primary prevention of stroke, ...

Forget Ozempic drug that Karan Johar was accused of taking for dramatic weight loss. Here are 8 expert ways to naturally ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

Terns Pharmaceuticals' (TERN) stock has risen somewhat due to some optimism around its early-stage clinical programs ...

For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Semaglutide and tirzepatide helped Texas woman Kathryn Dean lose 18kg and keep the weight off, and she is no longer diagnosed ...

Researchers examine the association between prescriptions of diabetes drugs and the incidence of alcohol intoxication and ...

Noom is rolling out two new solutions that aim to make it easier for employers and members to manage GLP-1s, and it's teaming ...

Noom Med with SmartRx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit ...

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announces the launch of a specialized program designed to ...